Product Information
AMOX-CLAV 875-125 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2838 per EA under NDC 00143924920. Its NADAC has been published 478 times since Aug 9, 2017.
FDA first approved this application on Aug 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
875; 125 mg/1; mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143924920
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMOXICILLIN; CLAVULANATE POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203824FDA Approved
8/23/2016
TE Code
AB
On Market Since
8/23/2016
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 875-125 MG TABLET has been published 478 times since Aug 9, 2017, and over the history we have for it it has declined 26.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2838 per EA |
|---|---|
| All-time high | $0.4414 (Jan 10, 2018) |
| All-time low | $0.2631 (Nov 20, 2024) |
| 52-week high | $0.3080 |
| 52-week low | $0.2711 |
| Median price | $0.3082 |
| Average price | $0.3169 |
| Largest weekly change | -26.7% (Jul 22, 2020) |
| Weeks tracked | 478 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amoxicillin and Clavulanate Potassium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Penicillin-class Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMOX-CLAV 875-125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 875-125 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2838 per EA (NDC 00143924920), effective Sep 30, 2026.
How has the price of AMOX-CLAV 875-125 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 875-125 MG TABLET has declined 26.5%. It has been tracked across 478 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 875-125 MG TABLET?
Since Aug 9, 2017, the NADAC for AMOX-CLAV 875-125 MG TABLET has ranged from a low of $0.2631 (Nov 20, 2024) to a high of $0.4414 (Jan 10, 2018), with a median of $0.3082 per EA.
Are there cheaper alternatives to AMOX-CLAV 875-125 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOX-CLAV 875-125 MG TABLET, is $0.2711 per EA — about 4% below AMOX-CLAV 875-125 MG TABLET.
Who manufactures AMOX-CLAV 875-125 MG TABLET?
AMOX-CLAV 875-125 MG TABLET (NDC 00143924920) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.